OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
José Miguel Rivera‐Caravaca, Stephanie L. Harrison, Benjamin J. R. Buckley, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 13
José Miguel Rivera‐Caravaca, Stephanie L. Harrison, Benjamin J. R. Buckley, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia
Anna Maisano, Marco Vitolo, Jacopo Francesco Imberti, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 15
Anna Maisano, Marco Vitolo, Jacopo Francesco Imberti, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 15
The Central Role of Extracellular Vesicles in the Mechanisms of Thrombosis in COVID-19 Patients With Cancer and Therapeutic Strategies
Haijiao Jing, Nan Zuo, Valerie A. Novakovic, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 6
Haijiao Jing, Nan Zuo, Valerie A. Novakovic, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 6
Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England’s prescription data during the COVID-19 pandemic (January 2019 to October 2020)
Ravina Barrett, James Hodgkinson
Therapeutic Advances in Cardiovascular Disease (2022) Vol. 16
Open Access | Times Cited: 6
Ravina Barrett, James Hodgkinson
Therapeutic Advances in Cardiovascular Disease (2022) Vol. 16
Open Access | Times Cited: 6
Clinical Outcomes of Anticoagulant Therapy in COVID-19 Patients with Pre-Existing Cardiovascular Diseases: A Systematic Review
Naif M. Alhawiti, Jamal M Alhawiti, Saif Alshalan, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 3767-3775
Open Access | Times Cited: 3
Naif M. Alhawiti, Jamal M Alhawiti, Saif Alshalan, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 3767-3775
Open Access | Times Cited: 3
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
Hrvoje Roguljić, Jerko Arambašić, Vjera Ninčević, et al.
Croatian Medical Journal (2022) Vol. 63, Iss. 3, pp. 287-294
Open Access | Times Cited: 4
Hrvoje Roguljić, Jerko Arambašić, Vjera Ninčević, et al.
Croatian Medical Journal (2022) Vol. 63, Iss. 3, pp. 287-294
Open Access | Times Cited: 4
Core shell stationary phase for a novel separation of some COVID-19 used drugs by UPLC-MS/MS Method: Study of grapefruit consumption impact on their pharmacokinetics in rats
Sally Tarek Mahmoud, Marwa A. Moffid, Rawda M. Sayed, et al.
Microchemical Journal (2022) Vol. 181, pp. 107769-107769
Open Access | Times Cited: 4
Sally Tarek Mahmoud, Marwa A. Moffid, Rawda M. Sayed, et al.
Microchemical Journal (2022) Vol. 181, pp. 107769-107769
Open Access | Times Cited: 4
An overview on role of nutrition on COVID-19 immunity: Accumulative review from available studies
Amir Hossein Mohammadi, Mohaddeseh Behjati, Masoumeh Karami, et al.
Clinical Nutrition Open Science (2022) Vol. 47, pp. 6-43
Open Access | Times Cited: 4
Amir Hossein Mohammadi, Mohaddeseh Behjati, Masoumeh Karami, et al.
Clinical Nutrition Open Science (2022) Vol. 47, pp. 6-43
Open Access | Times Cited: 4
O uso dos Anticoagulantes Orais de Ação Direta (DOACs) como terapia anticoagulante na COVID-19
Eduardo Macedo Sousa, Gustavo Elias Ferreira Neto, Henrique Moura Lobo, et al.
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 2, pp. e14951-e14951
Open Access
Eduardo Macedo Sousa, Gustavo Elias Ferreira Neto, Henrique Moura Lobo, et al.
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 2, pp. e14951-e14951
Open Access
Cardiovascular medications and its relations with COVID-19 survival
Sundas Butt, Dania M.N. Eltalib, Samina Alim, et al.
Elsevier eBooks (2024), pp. 39-63
Closed Access
Sundas Butt, Dania M.N. Eltalib, Samina Alim, et al.
Elsevier eBooks (2024), pp. 39-63
Closed Access
Development of a multivariate model with desirability-based optimization for simultaneous determination of five co-administrated drugs for the management of COVID-19 infection in their dosage forms via validated RP-HPLC method
Sonia T. Hassib, Marwa A. Moffid, Noha A. Aly, et al.
Journal of Liquid Chromatography & Related Technologies (2022) Vol. 45, Iss. 13-16, pp. 191-203
Closed Access | Times Cited: 3
Sonia T. Hassib, Marwa A. Moffid, Noha A. Aly, et al.
Journal of Liquid Chromatography & Related Technologies (2022) Vol. 45, Iss. 13-16, pp. 191-203
Closed Access | Times Cited: 3
Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19
S. А. Mishinova, Yu. М. Gomon, А. С. Колбин, et al.
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2023), Iss. 1, pp. 34-46
Open Access | Times Cited: 1
S. А. Mishinova, Yu. М. Gomon, А. С. Колбин, et al.
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2023), Iss. 1, pp. 34-46
Open Access | Times Cited: 1
Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study
Parth Shah, Kim Magee, Kiara H. Buccellato, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Parth Shah, Kim Magee, Kiara H. Buccellato, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
Adel Khalifa Hamad
Journal of Acute Disease (2022) Vol. 11, Iss. 6, pp. 212-221
Open Access
Adel Khalifa Hamad
Journal of Acute Disease (2022) Vol. 11, Iss. 6, pp. 212-221
Open Access
